Your browser doesn't support javascript.
loading
Small Extracellular Vesicles Promote Stiffness-mediated Metastasis.
Sneider, Alexandra; Liu, Ying; Starich, Bartholomew; Du, Wenxuan; Nair, Praful R; Marar, Carolyn; Faqih, Najwa; Ciotti, Gabrielle E; Kim, Joo Ho; Krishnan, Sejal; Ibrahim, Salma; Igboko, Muna; Locke, Alexus; Lewis, Daniel M; Hong, Hanna; Karl, Michelle N; Vij, Raghav; Russo, Gabriella C; Gómez-de-Mariscal, Estibaliz; Habibi, Mehran; Muñoz-Barrutia, Arrate; Gu, Luo; Eisinger-Mathason, T S Karin; Wirtz, Denis.
Afiliación
  • Sneider A; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Liu Y; Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Starich B; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Du W; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Nair PR; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Marar C; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Faqih N; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Ciotti GE; Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Kim JH; Department of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Krishnan S; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Ibrahim S; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Igboko M; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Locke A; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Lewis DM; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Hong H; Johns Hopkins Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Karl MN; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Vij R; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
  • Russo GC; Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Sciences-Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
  • Gómez-de-Mariscal E; Bioengineering and Aerospace Engineering Department, Universidad Carlos III de Madrid, Leganés, Spain.
  • Habibi M; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Muñoz-Barrutia A; Johns Hopkins Breast Center, Johns Hopkins Bayview Medical Center, Baltimore, Maryland.
  • Gu L; Bioengineering and Aerospace Engineering Department, Universidad Carlos III de Madrid, Leganés, Spain.
  • Eisinger-Mathason TSK; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Wirtz D; Department of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland.
Cancer Res Commun ; 4(5): 1240-1252, 2024 May 09.
Article en En | MEDLINE | ID: mdl-38630893
ABSTRACT
Tissue stiffness is a critical prognostic factor in breast cancer and is associated with metastatic progression. Here we show an alternative and complementary hypothesis of tumor progression whereby physiologic matrix stiffness affects the quantity and protein cargo of small extracellular vesicles (EV) produced by cancer cells, which in turn aid cancer cell dissemination. Primary patient breast tissue released by cancer cells on matrices that model human breast tumors (25 kPa; stiff EVs) feature increased adhesion molecule presentation (ITGα2ß1, ITGα6ß4, ITGα6ß1, CD44) compared with EVs from softer normal tissue (0.5 kPa; soft EVs), which facilitates their binding to extracellular matrix proteins including collagen IV, and a 3-fold increase in homing ability to distant organs in mice. In a zebrafish xenograft model, stiff EVs aid cancer cell dissemination. Moreover, normal, resident lung fibroblasts treated with stiff and soft EVs change their gene expression profiles to adopt a cancer-associated fibroblast phenotype. These findings show that EV quantity, cargo, and function depend heavily on the mechanical properties of the extracellular microenvironment.

SIGNIFICANCE:

Here we show that the quantity, cargo, and function of breast cancer-derived EVs vary with mechanical properties of the extracellular microenvironment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pez Cebra / Neoplasias de la Mama / Microambiente Tumoral / Vesículas Extracelulares Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Commun Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pez Cebra / Neoplasias de la Mama / Microambiente Tumoral / Vesículas Extracelulares Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Commun Año: 2024 Tipo del documento: Article
...